Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Biomedicines
|
October 29, 2025
Programmed-Cell-Death-Related Signature Reveals Immune Microenvironment Characteristics and Predicts Therapeutic Response in Diffuse Large B Cell Lymphoma
Donghui Xing, Kaiping Luo, Xiang He, et al.
Frontiers in Pharmacology
|
February 3, 2022
Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer
Le Deng, Qipeng Huang, Jiang Wang, et al.
BMC Nephrology
|
October 15, 2025
Efficacy and safety of hydroxychloroquine in IgA nephropathy with nasopharyngeal or intestinal mucosal and non-mucosal infections
Ran Zhang, Yang Yang, Yan Yan, et al.
EMBO Molecular Medicine
|
October 14, 2025
Glycine decarboxylase advances IgA nephropathy by boosting mesangial cell proliferation through the pyrimidine pathway
Yi Xiong, Fang Zeng, Kaiping Luo, et al.
Current Molecular Medicine
|
January 16, 2026
A Cuproptosis-related lncRNA Signature for Prognostic Stratification and Immunotherapeutic Implications in Lung Adenocarcinoma
Yanan Jiang, Donghui Xing, Kaiping Luo, et al.
European Journal of Pharmacology
|
May 19, 2025
Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage
Yang Yang, Yuxin Zhang, Ran Zhang, et al.
Drug Design, Development and Therapy
|
May 19, 2026
Is Rituximab Suitable for Patients with Idiopathic Membranous Nephropathy Who are Seronegative for Anti-PLA2R Antibody?
Yang Yang, Xiaojie Xie, Fan Yuan, et al.
Frontiers in Immunology
|
April 3, 2026
A multicenter retrospective cohort study on the efficacy and safety of mycophenolate mofetil plus hydroxychloroquine therapy in IgA nephropathy
Yang Yang, Jing Ning, Fang Zeng, et al.
Cell Death Discovery
|
May 1, 2024
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
Wenqi Wu, Yanan Jiang, Donghui Xing, et al.
Frontiers in Pharmacology
|
March 19, 2025
Efficacy and safety of Kunxian in IgA nephropathy
Yang Yang, Xiang Li, Honghong Zou, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Biomedicines
|
October 29, 2025
Programmed-Cell-Death-Related Signature Reveals Immune Microenvironment Characteristics and Predicts Therapeutic Response in Diffuse Large B Cell Lymphoma
Donghui Xing, Kaiping Luo, Xiang He, et al.
Frontiers in Pharmacology
|
February 3, 2022
Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer
Le Deng, Qipeng Huang, Jiang Wang, et al.
BMC Nephrology
|
October 15, 2025
Efficacy and safety of hydroxychloroquine in IgA nephropathy with nasopharyngeal or intestinal mucosal and non-mucosal infections
Ran Zhang, Yang Yang, Yan Yan, et al.
EMBO Molecular Medicine
|
October 14, 2025
Glycine decarboxylase advances IgA nephropathy by boosting mesangial cell proliferation through the pyrimidine pathway
Yi Xiong, Fang Zeng, Kaiping Luo, et al.
Current Molecular Medicine
|
January 16, 2026
A Cuproptosis-related lncRNA Signature for Prognostic Stratification and Immunotherapeutic Implications in Lung Adenocarcinoma
Yanan Jiang, Donghui Xing, Kaiping Luo, et al.
European Journal of Pharmacology
|
May 19, 2025
Evaluation of immunotherapy for idiopathic membranous nephropathy based on risk stratification and pathological stage
Yang Yang, Yuxin Zhang, Ran Zhang, et al.
Drug Design, Development and Therapy
|
May 19, 2026
Is Rituximab Suitable for Patients with Idiopathic Membranous Nephropathy Who are Seronegative for Anti-PLA2R Antibody?
Yang Yang, Xiaojie Xie, Fan Yuan, et al.
Frontiers in Immunology
|
April 3, 2026
A multicenter retrospective cohort study on the efficacy and safety of mycophenolate mofetil plus hydroxychloroquine therapy in IgA nephropathy
Yang Yang, Jing Ning, Fang Zeng, et al.
Cell Death Discovery
|
May 1, 2024
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
Wenqi Wu, Yanan Jiang, Donghui Xing, et al.
Frontiers in Pharmacology
|
March 19, 2025
Efficacy and safety of Kunxian in IgA nephropathy
Yang Yang, Xiang Li, Honghong Zou, et al.
Page
of 3